Nouvelles

Filtrer par tags
Saguaro Biosciences Partners With Global Pharma Leader to Advance Drug Discovery

Saguaro Biosciences s'associe à un acteur pharmaceutique mondial pour innover en découverte de médicaments

-- Projet financé par le programme Quantum Leap du CQDM -- Montréal, QUÉBEC, le 11 novembre 2025 – Le CQDM et Saguaro Biosciences sont fières d’annoncer que Saguaro Biosciences a reçu plus de 780 000...
Saguaro Biosciences Partners with Bio-Techne to Distribute Innovative Live-Cell Imaging Reagents

Saguaro Biosciences Partners with Bio-Techne to Distribute Innovative Live-Cell Imaging Reagents

October 15th, 2025. QUEBEC CITY--(BUSINESS WIRE)--Saguaro Biosciences, a pioneer in non-toxic live cell reagents for enhanced drug insights, announces a new distribution agreement with Bio-Techne Corporation (NASDAQ:TECH), a global provider of life science tools, reagents...
Saguaro Biosciences Secures $3M in Seed Funding to Transform Cell Biology Research

Saguaro Biosciences Secures $3M in Seed Funding to Transform Cell Biology Research

June 04th, 2024. QUEBEC CITY--(BUSINESS WIRE)--Saguaro Biosciences, a pioneering developer of live cell reagents for AI-enhanced discoveries, today announced the successful closing of a $3 million seed funding round, comprised of equity investments and non-dilutive...
Saguaro and Funakoshi Enter Distribution Agreement to make New Non-Toxic Dye Technology Available to Japan

Saguaro and Funakoshi Enter Distribution Agreement to make New Non-Toxic Dye Technology Available to Japan

November 17th, 2022. QUEBEC CITY & TOKYO--(BUSINESS WIRE)--Saguaro Technologies inc., a cell culture product company that offers a first-of-a-kind dye technology, and Funakoshi Co., Ltd., a top Japanese distributor of life science reagents and products,...
Saguaro Announces Exclusive Worldwide License Agreement with Sunnybrook Research Institute for ChromaLive™ dyes

Saguaro Announces Exclusive Worldwide License Agreement with Sunnybrook Research Institute for ChromaLive™ dyes

March 23rd, 2022. QUEBEC CITY (NEWS WIRE) Bringing new biology to light! QUÉBEC CITY, March 23, 2022 /CNW/ - Saguaro Technologies inc. announces today an exclusive worldwide license agreement with Sunnybrook Research Institute (SRI) on small molecules...
Saguaro Closes $1.1M Start-Up Funding to Offer New Drug Discovery Technologies That Help Fight Human Disease

Saguaro obtient un financement de démarrage de 1,1 million de dollars pour proposer de nouvelles technologies de découverte de médicaments qui aident à lutter contre les maladies humaines

16 février 2022. QUÉBEC ( BUSINESS WIRE ) Saguaro Technologies Inc. annonce la clôture d'un financement de démarrage de 1,1 million de dollars mené par un investisseur biotechnologique chevronné et comprenant un financement par subvention...

Intéressé par nos colorants cellulaires vivants?

Rejoignez les plus de 150 entreprises pharmaceutiques et de biotechnologie qui utilisent les colorants non toxiques de Saguaro

Thanks for contacting us. We'll get back to you as soon as possible.

Contactez-nous